• Customer Login
  • Search
KindredBio
  • About
    • Background
    • KindredBio Leadership
    • Board of Directors
  • Pipeline
    • Feline Pipeline
    • Canine Pipeline
    • Clinical Trials
  • Products
    • Zimeta™ (dipyrone injection)
  • Technology
    • Veterinary Recombinant Biologics
    • Manufacturing Process
  • Education
    • Continuing Education
    • KINections
  • Investors
    • Investor Overview
    • Press Releases
    • Events & Presentations
    • Corporate Governance
    • Stock Information
    • Financial Information
    • Investor Resources
  • News
    • Press Releases
  • Contact Us
    • Contact Us
    • Careers
  • Menu

login

You are here: Home / login
Username
Password

» Lost your Password?

News

  • Kindred Biosciences to Announce Second Quarter 2020 Financial ResultsJuly 23, 2020 - 8:33 am
  • Kindred Biosciences Announces Plan to Strengthen its Strategic PositionJune 8, 2020 - 4:04 pm
  • Kindred Biosciences Announces COVID-19 Vaccine Manufacturing Agreement with VaxartMay 20, 2020 - 8:02 am

Events

  • Event: Kindred Biosciences to Announce Second Quarter 2020 Financial ResultsJuly 23, 2020 - 8:41 am
  • Event: Kindred Biosciences to Present at Stifel 2020 Virtual Jaws & Paws ConferenceMay 13, 2020 - 8:39 am
  • Event: Kindred Biosciences to Announce First Quarter 2020 Financial ResultsApril 23, 2020 - 8:37 am
$4.43 Stock is Down -0.02 (-0.45%)
KIN (Common Stock)
Previous Close Volume
$4.45 45,959
Intraday High Intraday Low
$4.49 $4.34
52 Week High 52 Week Low
$11.93 $3.10
Exchange: NASDAQ CM

KindredBio proudly supports
Rabies Free Africa

Contact Us | Careers | Privacy Policy | Website Terms of Use | Forward Looking Statements
© Copyright 2012-2020 | Kindred Biosciences, Inc. | 1555 Bayshore Hwy. Suite 200 Burlingame, CA 94010
Scroll to top